Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
9.49
+0.16 (1.71%)
Feb 6, 2026, 4:00 PM EST - Market closed
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $826.79 million as of February 6, 2026. Its market cap has increased by 106.92% in one year.
Market Cap
826.79M
Enterprise Value
888.67M
1-Year Change
106.92%
Ranking
Category
Stock Price
$9.49
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $826.79M, an increase of 83.35%. That is a compound annual growth rate of 5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 825.18M | 9.42% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 938.38M |
| BridgeBio Oncology Therapeutics | 935.07M |
| ArriVent BioPharma | 909.43M |
| Annexon | 900.30M |
| Bicara Therapeutics | 896.78M |
| Arvinas | 859.96M |
| Maravai LifeSciences Holdings | 836.16M |
| Xencor | 823.36M |